Pieter Pretorius qualified in medicine (MBChB - cum laude) from the University of the Free State in Bloemfontein, South Africa in 1993.
He attended Oxford University on a Rhodes scholarship where he completed an MSc in Radiology. He was appointed as a Specialist Registrar in Radiology and subsequently in Neuroradiology at the Radcliffe Infirmary in Oxford.
In 2005 he was appointed as a Consultant Neuroradiologist in the Oxford University Hospitals NHS Foundation Trust where has worked as a full time Diagnostic Neuroradiologist since. His clinical role involves diagnostic Neuroradiology and Head & Neck Radiology, specifically the interpretation of MRI and CT scans of the brain, spine, skull base and head & neck in adults and children.
He has particular interests in Neuro-oncological imaging, skull base imaging including imaging of the temporal bones and hearing apparatus as well as imaging of patients with Neurofibromatosis type 2.
Honorary Senior Clinical Research Fellow
My research interests lie in the translation of advances in neuroimaging to clinical applications relevant to brain tumour imaging, traumatic brain injury and other areas within clinical Neuroradiology.
I collaborate with imaging scientists in FMRIB as well as clinical colleagues in Neurosurgery, Oncology, and Neuropathology to explore imaging approaches aimed at providing more accurate preoperative diagnosis of brain tumours and to provide clinically relevant prognostic and treatment response information in patients with brain tumours.
I also collaborate with clinical colleagues in the Oxford Regional NF2 Service on research aimed at a better understanding of the phenotypes and natural history of the condition as well as improving imaging surveillance and treatment response assessment.
To start immune therapy or not? An unusual presentation of longitudinally extensive transverse myelitis with pyrexia
Rounis E. et al, (2018), Journal of Neurology, 265, 1463 - 1465
Adult-Onset Recurrent Bacterial Meningitis: Immunological Red Herrings
Gilchrist JJ. et al, (2018), Clinical Infectious Diseases, 66, 635 - 636
Genetic Severity Score predicts clinical phenotype in NF2
Halliday D. et al, (2017), Journal of Medical Genetics, 54, 657 - 664
Early detection of cerebral microbleeds following traumatic brain injury using MRI in the hyper-acute phase
Lawrence TP. et al, (2017), Neuroscience Letters, 655, 143 - 150
The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2
Morris KA. et al, (2017), Journal of Neurosurgery: Spine, 26, 474 - 482